IPO Trending
CORONAEQ / NSE, BSEListed
Corona Remedies

Corona Remedies Limited, incorporated in August 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of products across key therapeutic areas including women’s healthcare, cardiology, pain management, urology, and multispecialty segments. As of December 2024, its portfolio includes 67 brands covering women’s health, cardio-diabetic care, pain relief, urology, and multispecialty products such as vitamins, minerals, nutrition, gastrointestinal, and respiratory medications. The company has established a strong pan-India presence with 2,598 medical representatives across 22 states, ensuring deep engagement with healthcare professionals and hospitals. It operates two manufacturing facilities in Gujarat, supporting its production and quality-focused growth strategy in the Indian Pharmaceutical Market.

₹1,008 - ₹1,062144.49x sub
Listed Price₹1470.00
Listing Gain+38.42%

IPO Schedule & Timeline

Bookbuilding IPO
Open08 Dec 2025
Close10 Dec 2025
Allotment11 Dec 2025
Listing15 Dec 2025

Quota Reservation & Application Lots

Quota Reservation (% Shares)

Anchor18,34,804 shares
29.73%
QIB12,21,729 shares
19.8%
HNI9,16,960 shares
14.86%
Retail21,39,573 shares
34.67%
Market Maker58,036 shares
0.94%

Minimum Application Lots

Retail1 Lot (14 shares)
₹14,868
sHNI14 Lots (196 shares)
₹2,08,152
bHNI68 Lots (952 shares)
₹10,11,024

Company Promoters

Dr. Kirtikumar Laxmidas MehtaNiravkumar Kirtikumar MehtaAnkur Kirtikumar Mehta

Company Background

Corona Remedies Limited, incorporated in August 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of products across key therapeutic areas including women’s healthcare, cardiology, pain management, urology, and multispecialty segments. As of December 2024, its portfolio includes 67 brands covering women’s health, card...

Financial Performance

Figures in ₹ Crores
Metric Breakdown

Revenue

Latest (Jun-25)₹348.56 Cr
Growth-60.9%
Revenue Trend (₹ in Crores)
0.0460.9921.81.4kMar-23Mar-24Mar-25Jun-25
PeriodRev (Cr)PAT (Cr)AssetsDebt
Jun-25348.5646.201,012.38106.65
Mar-251,202.35149.43929.8662.70
Mar-241,020.9390.50830.58134.14
Mar-23891.1084.93595.022.33

Key Performance Indicators (KPIs)

PeriodEPSROEROCEP/E (Pre)P/E (Post)
Jun-257.557.61%11.28%035.15
Mar-2524.4327.50%41.32%43.470
Mar-2414.820.36%31.19%00

Peer Comparison & Valuation

Financial Performance

Corona Remidies Limited

NAV/Share (₹)99.14
RONW(%)24.65
EPS (Basic) (₹)24.43

Abbott India Ltd

NAV/Share (₹)1,992.14
RONW(%)33.41
EPS (Basic) (₹)665.62

Alkem Laboratories Ltd

NAV/Share (₹)1,002.37
RONW(%)18.07
EPS (Basic) (₹)181.11

Eris Lifesciences Ltd

NAV/Share (₹)209.73
RONW(%)12.21
EPS (Basic) (₹)25.85

Glaxosmithkline Pharmaceuticals Ltd

NAV/Share (₹)115.19
RONW(%)47.54
EPS (Basic) (₹)54.76

J.b.chemicals & Pharmaceuticals Ltd

NAV/Share (₹)220.88
RONW(%)19.21
EPS (Basic) (₹)42.45

Mankind Pharma Limited

NAV/Share (₹)352.51
RONW(%)13.89
EPS (Basic) (₹)49.28

Pfizer Ltd

NAV/Share (₹)921.88
RONW(%)18.20
EPS (Basic) (₹)167.79

Sanofi India Ltd

NAV/Share (₹)373.68
RONW(%)48.05
EPS (Basic) (₹)179.46

Torrent Pharmaceuticals Ltd

NAV/Share (₹)224.28
RONW(%)25.18
EPS (Basic) (₹)56.47

Valuation

Corona Remidies Limited

P/E(X)0
CMP* (₹)0
Face value (₹)0

Abbott India Ltd

P/E(X)45.17
CMP* (₹)0
Face value (₹)0

Alkem Laboratories Ltd

P/E(X)31.39
CMP* (₹)0
Face value (₹)0

Eris Lifesciences Ltd

P/E(X)25.85
CMP* (₹)0
Face value (₹)0

Glaxosmithkline Pharmaceuticals Ltd

P/E(X)46.87
CMP* (₹)0
Face value (₹)0

J.b.chemicals & Pharmaceuticals Ltd

P/E(X)42.45
CMP* (₹)0
Face value (₹)0

Mankind Pharma Limited

P/E(X)45.77
CMP* (₹)0
Face value (₹)0

Pfizer Ltd

P/E(X)29.63
CMP* (₹)0
Face value (₹)0

Sanofi India Ltd

P/E(X)24.47
CMP* (₹)0
Face value (₹)0

Torrent Pharmaceuticals Ltd

P/E(X)65.91
CMP* (₹)0
Face value (₹)0

Broker & Analyst Reviews

Review Not Available

Institutional broker reviews and analyst reports have not been released for this issue yet. Reviews are typically published 2 to 3 days prior to the issue opening date.

IPO Allotment & Registrar Status

Official Registrar: Bigshare Services Private Limited

Allotment Finalized
Allotment Date
11 Dec 2025
Official Status
Out / Finalized
Registrar
Bigshare Services Private Limited
Listing Date
15 Dec 2025

Official Allotment Verification Links

Official Registrar Portal
Bigshare Services Private Limited

Direct allotment verification on the official registrar portal appointed for Corona Remedies. Check with PAN or Application No.

Check on Registrar Portal
Stock Exchange Portal
BSE India Investor Portal

Official Bombay Stock Exchange investor verification channel using Issue Name and PAN Number.

Check on BSE India

Allotment Schedule & Milestones

IST
1. Allotment Finalization11 Dec 2025Basis of allotment declared
2. Refund Initiation1 day post allotmentUPI / ASBA mandate unblocked
3. Demat CreditPrior to listingShares credited to CDSL/NSDL
4. Listing Date15 Dec 2025Trading commences on exchange

How to Check Corona Remedies Allotment Online

1Open Portal

Click on the official registrar link or BSE portal button above.

2Select Company

Select Corona Remedies from the issue drop-down list.

3Enter Details

Select PAN, Application No., or DP Client ID and type your details.

4View Allocation

Click Submit to check your allotted share count and status.

Prospectus & Official Filings

Allotment FAQs & Help

About Corona Remedies IPO

Complete issue overview for Corona Remedies (CORONA) IPO. The issue features an equity share price band of ₹1008 – ₹1062 per share with a minimum retail lot size of 14 Shares (minimum application amount of ₹14,868). Explore live market tracking on our GMP Tracker, compare against All IPO GMP Today, or view category bidding on the Subscription Page. Verify official allotment via IPO Registrars or review participating investment bankers in our Lead Managers Directory.

Frequently Asked Questions